ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study

NCT06028451 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2023-10-10

No results posted yet for this study

Summary

To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.

Conditions

  • Invasive Aspergillosis

Interventions

OTHER

Record the information data

Record the information data

Sponsors & Collaborators

  • Southeast University, China

    lead OTHER

Principal Investigators

  • Jingyuan Xu, M.D. · Southeast University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2024-09-15
Completion
2024-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06028451 on ClinicalTrials.gov